FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling (Q52205708)
scientific article published in September 1999
Language:
(P31) (Q13442814)
(P304) 899-910
(P433) 9
(P478) 39
(P577) Wednesday, September 1, 1999
(P921) (Q718753)
(P1433) (Q7743562)
(P1476) "FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling" (language: en)
(P2093) Davit B
Reynolds K
Yuan R
Ajayi F
Conner D
Fadiran E
Gillespie B
Sahajwalla C
Huang SM
Lesko LJ
(P2860) (Q30582507)
(Q41922262)
(Q36851934)
(Q36750350)
(Q32063097)
(Q41692688)
(Q41734947)
(Q34738805)
(Q41303053)
(Q34064351)
(Q36094057)
(Q51553057)
(Q39864969)
(Q34366708)
(Q48001182)
(Q34346469)
(Q52059524)
(Q50887850)
(Q28369686)
(Q34750480)
(Q46055776)
(Q46050952)
(Q41027740)
(Q59915037)
(Q73552417)
(Q72316122)
(Q74321732)
(Q95819985)
(Q74458820)
(Q77542483)
(Q73398522)
(Q73846480)
(Q77360259)
(Q68045940)
other details
description scientific article published in September 1999

External Links